Navigation Links
SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences
Date:2/6/2008

SAN DIEGO, Feb. 6 /PRNewswire-FirstCall/ -- SGX Pharmaceuticals, Inc. (Nasdaq: SGXP) announced today that the Company will be presenting at two upcoming investor conferences. The conference information is as follows:

-- 10th Annual BIO CEO & Investor Conference: Wednesday, February 13, 2008

at 1:15 PM Eastern Standard Time at the Waldorf=Astoria, New York City.

-- Roth 20th Annual OC Growth Stock Conference: Tuesday, February 19, 2008

at 11:30 AM Pacific Standard Time at the Ritz Carlton Laguna Niguel,

California.

A live webcast of both presentations will be available under the investor relations section of the Company's website at http://www.sgxpharma.com. Replays of the presentation will be available for 90 days following the event. Please connect to the Company's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About SGX Pharmaceuticals

SGX Pharmaceuticals is a biotechnology company focused on the discovery, development and commercialization of innovative cancer therapeutics. The SGX oncology pipeline includes drug candidates from its FAST(TM) drug discovery platform, such as SGX523, a cMET kinase inhibitor currently in Phase 1 clinical studies, next generation BCR-ABL inhibitors being developed by SGX and in partnership with Novartis, and JAK2 inhibitors. More information on the pipeline and drug discovery platform can be found at http://www.sgxpharma.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Anadys Pharmaceuticals to Present at the BIO CEO & Investor Conference
2. Memory Pharmaceuticals to Present at the 10th Annual BIO CEO & Investor Conference
3. MiddleBrook Pharmaceuticals to Present at BIO CEO & Investor Conference 2008
4. Celator(R) Pharmaceuticals to Present at 10th Annual BIO CEO and Investor Conference
5. Keryx Biopharmaceuticals Announces Upcoming Corporate Presentations
6. Anthera Pharmaceuticals Forms Scientific Advisory Board
7. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
8. Poniard Pharmaceuticals Appoints Robert De Jager, M.D., as Chief Medical Officer
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 5, 2008 in New York
10. Amylin Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
11. Koronis Pharmaceuticals Announces Appointment of Daniel H. Petree and George R. Painter, Ph.D. to Board of Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , Former Majority Leader Richard Gephardt Br...dicine, Biotech Communities for "Best and Brighte...Y, N.J., Dec. 1 Several...maceuticals, research, medicine and technology gat...ss the importance of medical innovation in New Jer...
(Date:12/1/2009)..., SARASOTA, Fla., Dec. 1 Expand...rey Biotechnics Inc. of Sarasota has appointed Lak...or. ,, Lake is located near Birmingham, Englan...cteria which serve the agricultural, waste water, ...o be hungry and to open drain fields, and clean up...
(Date:12/1/2009)..., SAN FRANCISCO, Dec. 1 The Burri...t half the value it lost in October. The Select,s ...llent month for the general markets with the Dow u...ue. The gains held firm in the final two trading d...uggish Thanksgiving holiday shopping and Dubai,s r...
(Date:12/1/2009)... EpiVax, Inc. today announced a co..., ROG; OTCQX: RHHBY) aimed at evaluating EpiVax&rs...d potentially reduce detrimental immune responses ...x collaboration, the EpiVax Tregitope technology w...city of protein therapeutics. , ...
Breaking Biology Technology:New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
Modine Manufacturing earnings drop
... Alliance, a group of investors, scientists and po... annual report that it is creating a roadmap for a...the area. , ,Founded in 2004, the alliance receive...rticipating academic institutions. That was not qu...ginally proposed, and which the alliance is still ...
...e these days, thanks to record oil prices and the ...ld be enhanced by producing more energy at home. W...e energy potential of crops such as corn, a quiet ...enetically engineered crops. , ,About 8.5 million...222 million acres in 2005, up 11 percent over the ...
Other Biology Technology:Biotech crops gaining acceptance, but their full promise has yet to be fulfilled 2Biotech crops gaining acceptance, but their full promise has yet to be fulfilled 3
(Date:12/1/2009)...ash University-led international research team has...f the next generation of solar cells. , Scientis...leagues from the universities of Wollongong and Ul...solar cells with a three-fold increase in energy c...rted tandem dye-sensitised solar cells. , Lead ...
(Date:12/1/2009)...s an ,abominable mystery, and it is a question whi... when did flowering plants evolve and how did they...dy in Ecology Letters reveals the evolutionary t... a major competitive advantage over rival species,..., The study, by Dr Tim Brodribb and Dr Taylor Fi...
(Date:12/1/2009)...cold, can spread among groups of people, research ...lifornia-San Diego and Harvard shows., Using lon...een following health conditions for more than 60 y...tend to share their loneliness with others. Gradua...ple moves to the fringes of social networks., We...
Breaking Biology News(10 mins):Innovation puts next-generation solar cells on the horizon 2How did flowering plants evolve to dominate Earth? 2Loneliness can be contagious 2Loneliness can be contagious 3Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 1Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 2Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 3Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle free Symphony 28TM 29 Transdermal Continuous Glucose Monitoring Syste 49185 4Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 1Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 2Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 3Arena Pharmaceuticals to Receive 24100 Million from Deerfield Management 49183 4This Fathers Day Give Dad a Gift Straight for the Heart 49181 1This Fathers Day Give Dad a Gift Straight for the Heart 49181 2This Fathers Day Give Dad a Gift Straight for the Heart 49181 3
...indings for the future,of California tiger salaman...hought about what happens when animal species inte...student Benjamin Fitzpatrick,(now on the faculty o...r Bradley Shaffer, was published recently in the P...line edition. , The salamander experts studied th...
... Inc., announced today that it has been awarded a ...ited States Defense Threat Reduction Agency (DTRA)...nners of this award were selected after an intense...academic, government, and industrial labs. , Nano...nostics, have been privately developing Gene-RADAR...
...million gift to the University of Michigan Health ...institute one with a mission of supporting fundam... causes, treatment and prevention of a broad range...al Research Institute, being established in the U-...whose funding and vision led to its creation. Mr. ...
Other Biology News:Nanobiosym awarded $2 million DTRA contract 2$22 million gift from Alfred Taubman launches new biomedical research institute 2$22 million gift from Alfred Taubman launches new biomedical research institute 3$22 million gift from Alfred Taubman launches new biomedical research institute 4
BspT107 I (HgiC I, Ban I) from Takara Mirus Bio
Bsu36 I from Promega
Mouse Anti-Verotoxin IIbeta Monoclonal Antibody, Unconjugated, Clone 457 from Santa Cruz Biotechnology, Inc.
Multiskan EX from Thermo Scientific
Biology Products: